We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Anne
Corbett
+44 1392 72 4464
a.m.j.corbett@exeter.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Long COVID
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The most concerning legacy of the Covid-19 pandemic is long COVID which affects at least 9.9% of people. About 25% of people with long COVID experience problems with their brain health, such as memory problems. These symptoms could stop people getting back to work and socialising and could increase their risk of dementia later in life. There is a need for a low-cost, effective treatment that can be rolled out on a large scale. Brain training offers a means to address this and digital delivery is a pragmatic way of delivering it.
The Reasoning Cognitive Training (ReaCT) brain training programme is available online and is known to help maintain brain health in older adults, but has not yet been tested in people with long COVID. This study aims to establish the effectiveness and cost-effectiveness of the ReaCT brain training programme in adults with cognitive impairment following Covid-19.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Already taking part in another active interventional clinical trial2. Having accessed the ReaCT programme online through participation in the PROTECT UK ageing cohort over the last 12 months3. Diagnosis of dementia
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Anne
Corbett
+44 1392 72 4464
a.m.j.corbett@exeter.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Exeter and funded by NIHR Central Commissioning Facility (CCF).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 57359
You can print or share the study information with your GP/healthcare provider or contact the research team directly.